Evidence map›Paper›PMID 38255962›Full record

ReviewInternational journal of molecular sciences2024

Tau Protein Alterations Induced by Hypobaric Hypoxia Exposure.

Eduardo Pena, Rocio San Martin-Salamanca, Samia El Alam, Karen Flores, Karem Arriaza

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Eduardo PenaHigh Altitude Medicine Research Center (CEIMA), Arturo Prat University, Iquique 1110939, Chile.
Rocio San Martin-SalamancaHigh Altitude Medicine Research Center (CEIMA), Arturo Prat University, Iquique 1110939, Chile.ORCID 0009-0004-0477-5759
Samia El AlamHigh Altitude Medicine Research Center (CEIMA), Arturo Prat University, Iquique 1110939, Chile.
Karen FloresHigh Altitude Medicine Research Center (CEIMA), Arturo Prat University, Iquique 1110939, Chile.
Karem ArriazaHigh Altitude Medicine Research Center (CEIMA), Arturo Prat University, Iquique 1110939, Chile.
Arturo Prat University · CL

Funding

GORE-FIC-TARAPACA BIP 400187737-0
6 · The paper itself

Abstract

Tauopathies are a group of neurodegenerative diseases whose central feature is dysfunction of the microtubule-associated protein tau (MAPT). Although the exact etiology of tauopathies is still unknown, it has been hypothesized that their onset may occur up to twenty years before the clear emergence of symptoms, which has led to questions about whether the prognosis of these diseases can be improved by, for instance, targeting the factors that influence tauopathy development. One such factor is hypoxia, which is strongly linked to Alzheimer's disease because of its association with obstructive sleep apnea and has been reported to affect molecular pathways related to the dysfunction and aggregation of tau proteins and other biomarkers of neurological damage. In particular, hypobaric hypoxia exposure increases the activation of several kinases related to the hyperphosphorylation of tau in neuronal cells, such as ERK, GSK3β, and CDK5. In addition, hypoxia also increases the levels of inflammatory molecules (IL-β1, IL-6, and TNF-α), which are also associated with neurodegeneration. This review discusses the many remaining questions regarding the influence of hypoxia on tauopathies and the contribution of high-altitude exposure to the development of these diseases.

Indexed as

Alzheimer DiseaseTauopathiesGlycogen Synthase Kinase 3 betaHumansHypoxiatau ProteinsGlycogen Synthase Kinase 3 betatau ProteinsAlzheimer’s diseasehigh altitudehypoxianeurologytauopathies

Identifiers

PMID38255962
PMCPMC10815386
OpenAlexW4390750319

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.